Codon-Directed Determination of the Biological Causes of Sequence Variants in Therapeutic Proteins-Reference-Cited by-同舟云学术

Codon-Directed Determination of the Biological Causes of Sequence Variants in Therapeutic Proteins

Published:2017-11-14 Issue:23 Volume:89 Page:12749-12755
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Jiang Tao¹,Song Hangtian²^ORCID,Slaney Thomas R.²,Wu Wei²,Langsdorf Erik²,Gupta Gargi²,Ludwig Richard²,Tao Li²,McVey Duncan²,Das Tapan K.²

Affiliation:

1. Department of Chemistry, The University of Michigan, 930 North University Avenue, Ann Arbor, Michigan 48109, United States

2. Analytical, Cell Line and Process Development, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, New Jersey 08534, United States

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.7b02914

Reference30 articles.

1. Antibody therapy of cancer

2. The growth and potential of human antiviral monoclonal antibody therapeutics

3. Enzyme replacement and enhancement therapies: lessons from lysosomal disorders

4. Biopharmaceutical benchmarks 2014

5. Assessing Genetic Heterogeneity in Production Cell Lines: Detection by Peptide Mapping of a Low Level Tyr to Gln Sequence Variant in a Recombinant Antibody

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High throughput and high confidence sequence variant analysis in therapeutic antibodies using Evosep One liquid chromatography tandem mass spectrometry with synthetic heavy peptides;Journal of Pharmaceutical and Biomedical Analysis;2022-09

2. Enhanced CHO Clone Screening: Application of Targeted Locus Amplification and Next‐Generation Sequencing Technologies for Cell Line Development;Biotechnology Journal;2019-05-15